Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas S Hawkins

Showing results (1-10 of 238) with videos related to

Pageof 24
Sort By:
Journal of Pediatric Hematology/Oncology|December 14, 2004
Transatlantic collaboration in pediatric oncology: now is the timeDouglas S Hawkins
Pediatric Blood & Cancer|June 18, 2011
Sarcomas gone bad: what to do about recurrent Ewing sarcomaDouglas S Hawkins
Pediatric Blood & Cancer|January 30, 2020
An unresolved issue in rhabdomyosarcoma treatment: The duration of chemotherapyGianni Bisogno, Douglas S Hawkins
Pediatric Blood & Cancer|July 11, 2023
Children's Oncology Group's 2023 blueprint for researchDouglas S Hawkins, Lia Gore
Pediatric Blood & Cancer|October 28, 2015
Second Malignant Neoplasms in Rhabdomyosarcoma: Victims of Our Own Success or an Underlying Genetic Predisposition Syndrome?Navin Pinto, Douglas S Hawkins
Pediatric Blood & Cancer|March 2, 2012
Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studiesSuman Malempati, Douglas S Hawkins
Expert Review of Anticancer Therapy|October 24, 2018
Larotrectinib for the treatment of TRK fusion solid tumorsTheodore W Laetsch, Douglas S Hawkins
Archives of Pediatrics & Adolescent Medicine|March 3, 2010
No evidence of a trial effect in newly diagnosed pediatric acute lymphoblastic leukemiaCarl Koschmann, Blythe Thomson, Douglas S Hawkins
Pediatric Blood & Cancer|September 12, 2020
Introducing INSTRuCT: An international effort to promote cooperation and data sharingDouglas S Hawkins, Gianni Bisogno, Ewa Koscielniak
Cancer|November 25, 2003
Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapyDouglas S Hawkins, Carola A S Arndt
Pageof 24

Showing results (1-10 of 238) with videos related to

Sort By:
Pageof 24
Journal of Pediatric Hematology/Oncology|December 14, 2004
Transatlantic collaboration in pediatric oncology: now is the timeDouglas S Hawkins
Pediatric Blood & Cancer|June 18, 2011
Sarcomas gone bad: what to do about recurrent Ewing sarcomaDouglas S Hawkins
Pediatric Blood & Cancer|January 30, 2020
An unresolved issue in rhabdomyosarcoma treatment: The duration of chemotherapyGianni Bisogno, Douglas S Hawkins
Pediatric Blood & Cancer|July 11, 2023
Children's Oncology Group's 2023 blueprint for researchDouglas S Hawkins, Lia Gore
Pediatric Blood & Cancer|October 28, 2015
Second Malignant Neoplasms in Rhabdomyosarcoma: Victims of Our Own Success or an Underlying Genetic Predisposition Syndrome?Navin Pinto, Douglas S Hawkins
Pediatric Blood & Cancer|March 2, 2012
Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studiesSuman Malempati, Douglas S Hawkins
Expert Review of Anticancer Therapy|October 24, 2018
Larotrectinib for the treatment of TRK fusion solid tumorsTheodore W Laetsch, Douglas S Hawkins
Archives of Pediatrics & Adolescent Medicine|March 3, 2010
No evidence of a trial effect in newly diagnosed pediatric acute lymphoblastic leukemiaCarl Koschmann, Blythe Thomson, Douglas S Hawkins
Pediatric Blood & Cancer|September 12, 2020
Introducing INSTRuCT: An international effort to promote cooperation and data sharingDouglas S Hawkins, Gianni Bisogno, Ewa Koscielniak
Cancer|November 25, 2003
Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapyDouglas S Hawkins, Carola A S Arndt
Pageof 24